Literature DB >> 31101317

Cutaneous Melanoma in the Elderly: Review of a Growing Problem.

N Iglesias-Pena1, S Paradela1, A Tejera-Vaquerizo2, A Boada3, E Fonseca1.   

Abstract

Cutaneous melanoma (CM) causes more deaths than any other skin tumor, and incidence and mortality rates have risen in recent years, especially in patients of advanced age. There are differences in the biological behavior of CM tumors in the elderly as well as differential management of the disease, evidently influenced by such factors as limited life expectancy, the high incidence of concomitant conditions in older patients, and issues of quality of life unrelated to CM itself. We review relevant current literature on the epidemiology, etiology, pathogenesis, and immunology of CM as well as research on the clinical features, prevention, and management of these tumors in the elderly.
Copyright © 2019 AEDV. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Anciano; Cirugía; Elderly; Ganglio centinela; Health services for the aged; Melanoma; Prognosis; Pronóstico; Review; Revisión; Sentinel lymph node; Servicio de salud para el anciano; Surgery

Mesh:

Year:  2019        PMID: 31101317     DOI: 10.1016/j.ad.2018.11.009

Source DB:  PubMed          Journal:  Actas Dermosifiliogr (Engl Ed)        ISSN: 2173-5778


  6 in total

Review 1.  Immunotherapy in the Treatment of Metastatic Melanoma: Current Knowledge and Future Directions.

Authors:  Massimo Ralli; Andrea Botticelli; Irene Claudia Visconti; Diletta Angeletti; Marco Fiore; Paolo Marchetti; Alessandro Lambiase; Marco de Vincentiis; Antonio Greco
Journal:  J Immunol Res       Date:  2020-06-28       Impact factor: 4.818

2.  Population-Based Study Detailing Cutaneous Melanoma Incidence and Mortality Trends in Canada.

Authors:  Santina Conte; Feras M Ghazawi; Michelle Le; Hacene Nedjar; Akram Alakel; François Lagacé; Ilya M Mukovozov; Janelle Cyr; Ahmed Mourad; Wilson H Miller; Joël Claveau; Thomas G Salopek; Elena Netchiporouk; Robert Gniadecki; Denis Sasseville; Elham Rahme; Ivan V Litvinov
Journal:  Front Med (Lausanne)       Date:  2022-03-03

3.  MrgprF acts as a tumor suppressor in cutaneous melanoma by restraining PI3K/Akt signaling.

Authors:  Qiushuo Shen; Yanfei Han; Kai Wu; Yaomei He; Xiulin Jiang; Peishen Liu; Cuifeng Xia; Qiuxia Xiong; Rui Liu; Qianming Chen; Yong Zhang; Song Zhao; Cuiping Yang; Yongbin Chen
Journal:  Signal Transduct Target Ther       Date:  2022-05-04

4.  Impact of the COVID-19 Pandemic on the Diagnosis and Prognosis of Melanoma.

Authors:  Antonio Martinez-Lopez; Pablo Diaz-Calvillo; Carlos Cuenca-Barrales; Trinidad Montero-Vilchez; Manuel Sanchez-Diaz; Agustin Buendia-Eisman; Salvador Arias-Santiago
Journal:  J Clin Med       Date:  2022-07-19       Impact factor: 4.964

5.  Potential effect of EGCG on the anti-tumor efficacy of metformin in melanoma cells.

Authors:  An'an Xu; Jeehyun Lee; Yueling Zhao; Yuefei Wang; Xiaoli Li; Ping Xu
Journal:  J Zhejiang Univ Sci B       Date:  2021-07-15       Impact factor: 3.066

6.  Sentinel Lymph Node Biopsy vs. Observation in Thin Melanoma: A Multicenter Propensity Score Matching Study.

Authors:  Antonio Tejera-Vaquerizo; Aram Boada; Simone Ribero; Susana Puig; Sabela Paradela; David Moreno-Ramírez; Javier Cañueto; Blanca de Unamuno-Bustos; Ana Brinca; Miguel A Descalzo-Gallego; Simona Osella-Abate; Paola Cassoni; Sebastian Podlipnik; Cristina Carrera; Sergi Vidal-Sicart; Ramón Pigem; Agustí Toll; Ramón Rull; Llucìa Alos; Celia Requena; Isidro Bolumar; Víctor Traves; Ángel Pla; Almudena Fernández-Orland; Ane Jaka; María Teresa Fernández-Figueras; Nina Anika Richarz; Ricardo Vieira; Rafael Botella-Estrada; Concepción Román-Curto; Lara Ferrándiz-Pulido; Nicolás Iglesias-Pena; Carlos Ferrándiz; Josep Malvehy; Pietro Quaglino; Eduardo Nagore
Journal:  J Clin Med       Date:  2021-12-15       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.